Drug Shortage Report for CAMPRAL
Report ID | 213971 |
Drug Identification Number | 02293269 |
Brand name | CAMPRAL |
Common or Proper name | ACAMPROSATE CALCIUM |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ACAMPROSATE CALCIUM |
Strength(s) | 333MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 84 BL |
ATC code | N07BB |
ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-12-16 |
Estimated end date | 2024-01-03 |
Actual end date | 2024-01-05 |
Shortage status | Resolved |
Updated date | 2024-01-10 |
Company comments | Transit Delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-01-10 | French | Compare |
v3 | 2024-01-10 | English | Compare |
v2 | 2023-12-21 | French | Compare |
v1 | 2023-12-21 | English | Compare |
Showing 1 to 4 of 4